Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

The clinical diagnosis of vascular dementia (VaD) is based on imaging criteria, and specific biochemical markers are not available. Here, we investigated the potential of cerebrospinal fluid (CSF) lipocalin 2 (LCN2), a secreted glycoprotein that has been suggested as mediating neuronal damage in vas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Commun
Main Authors: Llorens, Franc, Hermann, Peter, Villar-Piqué, Anna, Diaz-Lucena, Daniela, Nägga, Katarina, Hansson, Oskar, Santana, Isabel, Schmitz, Matthias, Schmidt, Christian, Varges, Daniela, Goebel, Stefan, Dumurgier, Julien, Zetterberg, Henrik, Blennow, Kaj, Paquet, Claire, Baldeiras, Inês, Ferrer, Isidro, Zerr, Inga
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6992814/
https://ncbi.nlm.nih.gov/pubmed/32001681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-14373-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados